| Molecular Formula | C23H21FO3 |
| Molar Mass | 364.41 |
| Density | 1.199±0.06 g/cm3(Predicted) |
| Boling Point | 540.8±50.0 °C(Predicted) |
| Solubility | 10 mM in DMSO |
| pKa | 4.70±0.10(Predicted) |
| Storage Condition | Sealed in dry,Room Temperature |
| In vitro study | TUG-891 displays similar signaling properties to the LCFA α-linolenic acid at human FFA4, including stimulation of Ca 2+ mobilization, β-arrestin-1 and β-arrestin-2 recruitment, and extracellular signal-regulated kinase phosphorylation. Activation of human FFA4 by TUG-891 also results in rapid phosphorylation and internalization of the receptor. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.744 ml | 13.721 ml | 27.442 ml |
| 5 mM | 0.549 ml | 2.744 ml | 5.488 ml |
| 10 mM | 0.274 ml | 1.372 ml | 2.744 ml |
| 5 mM | 0.055 ml | 0.274 ml | 0.549 ml |
| biological activity | TUG-891 is an effective, selective long chain free fatty acid (LCFA) receptor 4 (FFA4/GPR120) agonist. |
| target | TargetValue FFA4/GPR120 () |
| Target | Value |
| in vitro study | TUG-891 displays similar signaling properties to the LCFA α-linolenic acid at human FFA4, including stimulation of Ca 2 mobilization, β-arrestin-1 and β-arrestin-2 recruitment, and extracellular signal-regulated kinase phosphorylation. Activation of human FFA4 by TUG-891 also results in rapid phosphorylation and internalization of the receptor. |